The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples